FBI ‘Operation Box Cutter’ Indicts Chinese Firms and Citizens Over Fentanyl Precursors, Terror‑Linked Cartel Ties

The Justice Department says a federal grand jury in Dayton, Ohio has indicted two China‑based pharmaceutical companies—Shandong Believe Chemical Company and Shandong Ranhang Biotechnology—and six Chinese nationals for allegedly selling and shipping chemical precursors used to manufacture fentanyl destined for the United States. Prosecutors allege that from July 2025 through January 2026 the companies used the defendants to openly market, negotiate and deliver cutting agents and fentanyl precursors to U.S. and foreign drug traffickers, directing American customers to pay in cryptocurrency that was later funneled into foreign financial institutions. The indictment also charges three of the defendants with providing chemical precursors and medetomidine, a powerful animal sedative, to a member of Mexico’s Cártel del Golfo, which the State Department has designated a foreign terrorist organization, triggering material‑support‑for‑terrorism counts. FBI Director Kash Patel called the FBI‑led, multi‑agency probe, code‑named Operation Box Cutter, a 'historic success' and highlighted what he described as 'groundbreaking' operational intelligence support from China’s Ministry of Public Security, an unusual level of cooperation given broader U.S.–China tensions. Officials say medetomidine can increase the yield of a kilogram of fentanyl at least twenty‑fold, producing millions of street doses—a reminder that the fight over synthetic‑opioid supply chains now runs through Chinese chemical exporters, Mexican cartels and U.S. crypto rails, even as overdose deaths and fentanyl politics remain front‑burner issues in Washington.